This Week in Science
In news this week, scientists and universities are asking US Congress "not to expand a $2 billion research program for small businesses " because it would likely cut money that could otherwise go toward research projects. (Fri, 03 Jul 2009 15:33:23 GMT)
Cardiff Univ. Uses $6.6M for Neuro-Genetics and Genomics Center
NEW YORK (GenomeWeb News) – Cardiff University in Wales has established a new center to study the genetic underpinnings of mental illnesses, and said that it will be funded with over £4 million ($6.6 million) from sources within the UK and from its own coffers. (Fri, 03 Jul 2009 15:33:13 GMT)
In Brief This Week: Roche NimbleGen; Aushon BioSystems; Saladax Biomedical; Mobidiag; Enigma Diagnostics
NEW YORK (GenomeWeb News) – Roche NimbleGen said this week that it has entered into a partnership with the Korea Centers for Disease Control and sequencing services firm Macrogen to conduct an eight-month copy number variation study of Korean individuals. (Fri, 03 Jul 2009 15:32:53 GMT)
S. Brenner on C. elegans
Over at Flies & Bikes, GrumpyBob has a post on a perspectives piece from Sydney Brenner in the latest issue of Genetics . "This brief article ... presents an account of the origins of Caenorhabditis elegans research, by the beast's main man," the blogger writes. (Fri, 03 Jul 2009 15:18:03 GMT)
Science and Religion, Science and Atheism
John Hawks has a post linking out to a survey published in the Guardian and conducted by the British Council, which polled 10,000 people in 10 countries to determine whether they believe in evolution, whether it should be taught, and whether beliefs in religion and evolution can be held simultaneously. (Fri, 03 Jul 2009 15:17:53 GMT)
No, This Is Not About Paternity Testing
Misha Angrist alerts readers about an upcoming conference at NIH focused on improving accuracy and standards for family histories. The meeting's open to anyone and will be held August 24-26 at NIH, and will also be webcast. (Fri, 03 Jul 2009 15:03:48 GMT)
Research and Markets: Fundamental Principles of Bayesian Analysis of Gene Expression Data Explored
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Bayesian Analysis of Gene Expression Data" to their offering. (Fri, 03 Jul 2009 14:40:00 GMT)
CFI's 'Omics Grants Broad in Scope
NEW YORK (GenomeWeb News) – The nearly C$670 million ($576.8 million) that the Canada Foundation for Innovation recently pumped into research projects and infrastructure will fund a range of genomics and proteomics studies and institutes spread across the nation. (Fri, 03 Jul 2009 13:48:09 GMT)
Genome-Wide Screen Turns Up Primate-Specific Genes
NEW YORK (GenomeWeb News) – In a paper scheduled to appear online this week in the Proceedings of the National Academy of Sciences , researchers from the Genome Institute of Singapore and Wayne State University used a genome-wide screen to try to fish out primate-specific sequences in the human genome. (Fri, 03 Jul 2009 13:47:59 GMT)
Cell Pathway May Be Key to Lung Cancer's Spread
Researchers express hope that finding will lead to treatments (Fri, 03 Jul 2009 13:31:33 GMT)
Cell Pathway May Be Key to Lung Cancer's Spread
FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of relapsed lung cancer. (Fri, 03 Jul 2009 13:02:37 GMT)
Risk Of Liver Cancer In Women With Hepatitis B Virus Infection Varies With Number Of Pregnancies
Risk for hepatocellular carcinoma, a primary malignancy of the liver, was statistically significantly higher among women with hepatitis B virus (HBV) infection than among women without the virus, according to a new study. (Fri, 03 Jul 2009 12:23:41 GMT)
What Drives Lung Cancer's Spread?
A new study reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone -- the two most prominent sites of lung cancer relapse. (Fri, 03 Jul 2009 12:23:15 GMT)
Research Reveals What Drives Lung Cancer's Spread
A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone the two most prominent sites of lung cancer relapse. The study will be published online in the journal Cell on July 2. (Fri, 03 Jul 2009 12:09:42 GMT)
What prompts lung cancer to spread
Washington, July 3: Researchers from Memorial Sloan-Kettering Cancer Centre claim to have identified a cellular pathway that is involved in spread of lung cancer. (Fri, 03 Jul 2009 10:48:54 GMT)
CLC Bio Reveals Biocomputing Solution At ISMB 2009 In Stockholm
Today, at the 17th international conference on Intelligent Systems for Molecular Biology (ISMB) and 8th European Conference on Computational Biology (ECCB) in Stockholm, Sweden, CLC bio has revealed their first turnkey biocomputing solution for analyzing and visualizing Next Generation Sequencing data, called CLC Genomics Machine. (Fri, 03 Jul 2009 09:31:10 GMT)
Francis vs. the Atheists: This Won't Be Pretty
At Framing Science , Matthew Nisbet uses today's premier of the movie Expelled to caution atheist scientists about going too far. He excerpts a Pew interview with Francis Collins , who breaks down why "the current crowd of seemingly angry atheists, who are using science as part of their argument that faith is irrelevant, do not speak for us," Collins says. (Fri, 03 Jul 2009 05:18:22 GMT)
Score One for Open Access
Publishing company Springer has acquired BioMed Central , the largest open access publisher with more than 180 peer-reviewed journals. Springer's Derk Haank said in a statement , "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade." (Fri, 03 Jul 2009 05:18:10 GMT)
Would that Be Doping, or Just Perfect Genetics?
OK, that may be a little harsh, but it's the theme of this Discover article about how advances in gene therapy and genetic manipulation may ultimately change the concept of athletes. (Fri, 03 Jul 2009 05:18:04 GMT)
Molecular Differences Found Between Embryonic Stem Cells And Reprogrammed Skin Cells
Researchers have found that embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another. (Fri, 03 Jul 2009 04:22:54 GMT)
OncQuest Labs launches K-RAS Mutation Analysis for diagnosis of colorectal & lung cancers
OncQuest Laboratories Ltd., a pioneer in Indian oncology clinical testing, has introduced the K-RAS Mutation Analysis for determining therapeutic response of the targeted therapies in colorectal and lung cancers. (Fri, 03 Jul 2009 02:49:08 GMT)
Health care brings architect to Arizona
Rebecca Olson's road to Phoenix was a bit twisty. But along the way, she obtained plenty of experience in health-care architecture, her specialty as associate principal with Phoenix-based Westlake Reed Leskosky. (Fri, 03 Jul 2009 00:52:33 GMT)
Major new e-science resource for biologists
The University of Manchester and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) have launched a major new e-science resource for biologists - which could accelerate research into treatments for H1N1 flu and cancer. (Fri, 03 Jul 2009 00:42:16 GMT)
'Jumping gene' diminishes the effect of a new type 2 diabetes risk gene
Research has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69. The researchers also found that the corresponding human gene (ZNF642) is especially active in overweight individuals with diabetes. The results of ... (Fri, 03 Jul 2009 00:13:17 GMT)
Osmetech Raises $8.6M Through Private Placement
NEW YORK (GenomeWeb News) – British molecular diagnostics firm Osmetech has raised £5.2 million ($8.6 million) through a private placement of around 262 million new ordinary shares at a price of 2p each. (Thu, 02 Jul 2009 22:17:53 GMT)
Study Reveals What Drives Lung Cancer's Spread
A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone – the two most prominent sites of lung cancer relapse. (Thu, 02 Jul 2009 20:44:48 GMT)
Scientists Find Molecular Differences Between Embryonic Stem Cells and Reprogrammed Skin Cells
UCLA researchers have found that embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another.The data from the study suggest that embryonic stem cells and the reprogrammed cells, known as induced pluripotent stem (iPS) cells, have overlapping ... (Thu, 02 Jul 2009 20:44:36 GMT)
UK's MRC Funds Fourth High-Throughput Sequencing Hub in Oxford with Over $3M
The UK's Medical Research Council said last week that it is funding a high-throughput sequencing center, based at the Wellcome Trust Centre for Human Genetics in Oxford, with approximately £2 million ($3.3 million), adding to more than £7 million in funding for three other UK-based sequencing hubs that the MRC announced this spring. (Thu, 02 Jul 2009 20:32:53 GMT)
CLC bio Expands Next Generation Sequencing Solutions with Digital Gene Expression by Tag Profiling
AARHUS, Denmark----CLC bio today announced the release of new versions of the desktop application CLC Genomics Workbench, version 3.6 and the award-winning enterprise platform CLC Genomics Server, version 1.6. (Thu, 02 Jul 2009 19:43:00 GMT)
Genetic sequencing gets personal
Price competition is coming to the rarified world of genome sequencing. (Thu, 02 Jul 2009 19:23:45 GMT)
CDRH, on the Move in Maryland, Limits Days for Test Submissions
The FDA's Center for Devices and Radiological Health expects to complete relocating to its new Maryland digs Aug. 3, and is urging researchers not to file regulatory submissions on certain days. (Thu, 02 Jul 2009 19:03:13 GMT)
BlueGnome to Market Rubicon Technology for IVF Studies
NEW YORK (GenomeWeb News) – BlueGnome will market Rubicon Genomics' technology along with its microarray-based aneuploidy chromosome screening and detection systems under a new non-exclusive agreement, Rubicon said today. (Thu, 02 Jul 2009 18:48:57 GMT)
Interleukin Sells Nutrition Branch for $4.6M
NEW YORK (GenomeWeb News) – Interleukin Genetics said today that it has sold its Alan James Group business to Pep Products, a subsidiary of Nutraceutical Corporation, for around $4.6 million in cash. (Thu, 02 Jul 2009 18:47:53 GMT)
AMP Lays Out Five 'Key' Points for US Gov't to Consider When Revamping Health-Care System
The Association for Molecular Pathology earlier this week released five "key principles" the federal government should keep in mind as it tries to revamp the nation’s health-care system. (Thu, 02 Jul 2009 18:17:53 GMT)
Meetings and Deadlines
Jul 17-19 Genetic Alliance Annual Meeting Genetic Alliance Bethesda, Md. Genetics (Thu, 02 Jul 2009 16:47:56 GMT)
Embryonic stem cells, reprogrammed skin cells have inherent differences
(PhysOrg.com) -- UCLA researchers have found that embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another. (Thu, 02 Jul 2009 16:33:17 GMT)
UCLA scientists find molecular differences between embryonic stem cells and reprogrammed skin cells
UCLA researchers have found that embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another. (Thu, 02 Jul 2009 16:13:38 GMT)
Research reveals what drives lung cancer's spread
( Memorial Sloan-Kettering Cancer Center ) A new study by researchers at Memorial Sloan-Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone -- the two most prominent sites of lung cancer relapse. The study will be published online in the journal Cell on July 2. (Thu, 02 Jul 2009 16:13:28 GMT)
This Week in Nature
Three genome-wide association studies published in Nature 's early online edition show that many common variants contribute to increased risk for developing schizophrenia -- not just large, rare structural variations. (Thu, 02 Jul 2009 16:02:53 GMT)
Illumina falls after 2Q revenue misses estimates
Shares of Illumina Inc. sank Thursday after the genetic analysis instrument maker said revenue in the second quarter fell short of its own forecast and Wall Street estimates. (Thu, 02 Jul 2009 16:00:37 GMT)
Back From the Brink, But Hurtling Toward Another One
The Amur tiger may have bounced back from the brink of extinction (there are now 500 in the wild and 421 in captivity, up from the 1940s low of 20 to 30) but a new study in Molecular Ecology says that their genetic diversity is the lowest ever measured for wild tigers, says the BBC. Further compounding the problem is that there are two populations of the wild tiger that do not intermingle as ... (Thu, 02 Jul 2009 15:48:23 GMT)
Scan of the Sample
And now for a moment of shameless self-promotion: if you haven't seen our new sister blog on clinical labs, The Sample , check it out. Some recent items: The search for a director for Kaiser Permanente's molecular genetics lab has dragged on for at least five weeks . The director, should they ever find one, will oversee the lab's "high-complexity molecular genetics mutation studies for an ... (Thu, 02 Jul 2009 15:48:13 GMT)
Dawkins and Venter: Their Egos Do Fit in the Same Room
Richard Dawkins stops by to see Craig Venter and gets a tour of his sequencing facility while chatting about the Human Genome Project and how the technology has changed in the intervening years. (Thu, 02 Jul 2009 15:47:53 GMT)
$500,000 Gruber Neuroscience Prize Awarded To Hall, Rosbash And Young
The 2009 Neuroscience Prize of The Peter and Patricia Gruber Foundation is being awarded to Jeffrey Hall, professor of neurogenetics at the University of Maine; Michael Rosbash, professor and director of the National Center for Behavioral Genomics at Brandeis University; and Michael Young, professor and head of the Laboratory of Genetics at Rockefeller University. (Thu, 02 Jul 2009 15:09:42 GMT)
Extensive and Rapid Diagnostic Assay for Herpesviral Infections in the Central Nervous System
HELSINKI, FINLAND--(Marketwire - July 2, 2009) - Mobidiag's CE-IVD-marked Prove-itT Herpes-test helps the clinician in targeting antiviral treatment correctly for patients with severe herpesviral infections Helsinki, Finland - June 2, 2009 - Finnish biotech company Mobidiag announces CE-marked herpesvirus microarray for rapid In Vitro Diagnostics (IVD) of life-threatening central nervous system ... (Thu, 02 Jul 2009 14:33:04 GMT)
Q&A: U of Zurich Team Develops Protein Inference Method to Eliminate Shotgun Proteomics Ambiguities
In a study published June 22 online in Genome Research , researchers describe a new peptide classification and protein inference method that helped them identify around 3,500 proteins in pollen — around 13 times the previously reported pollen proteome. (Thu, 02 Jul 2009 14:32:53 GMT)
New biomarker method may help detection of cancer in early stage
A team of researchers has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. (Thu, 02 Jul 2009 12:48:25 GMT)
New e-Science Service Could Accelerate Cancer Research
The University of Manchester and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) have launched a major new e-science resource for biologists which could accelerate research into treatments for H1N1 flu and cancer. Biocatalogue. (Thu, 02 Jul 2009 12:24:54 GMT)
Genome Canada Appoints New Chair of the Board
OTTAWA, ONTARIO--(Marketwire - July 2, 2009) - Genome Canada is pleased to announce the appointment of Dr. C. Thomas Caskey as Chair of the Board of Directors, effective June 18, 2009. Dr. Caskey has been a member of Genome Canada's Board of Directors for a number of years and has served in various capacities on a number of committees. He was appointed Vice-Chair in 2008. Dr. Caskey currently ... (Thu, 02 Jul 2009 12:18:57 GMT)
Roche NimbleGen CNV Arrays Selected for Landmark Korean Copy Number Variation Study
MADISON, Wis.----Roche NimbleGen has entered into a partnership with the Korea Centers for Disease Control and Prevention and Macrogen, Inc. to conduct an 8-month intensive Copy Number Variation study of Korean individuals. (Thu, 02 Jul 2009 12:00:00 GMT)
£4m mental health genetics centre
A research centre which will use genetics to study conditions ranging from schizophrenia to dyslexia is being launched. (Thu, 02 Jul 2009 11:11:04 GMT)
N.C. Research Campus showcases its equipment, expertise
By Emily Ford eford@salisburypost.com KANNAPOLIS — The David H. Murdock Research Institute has started showcasing the array of equipment and experti ... (Thu, 02 Jul 2009 08:00:09 GMT)
Getting to Know the Gibbon
A new paper out in PLoS Genetics today outlines a high-resolution synteny map that illustrates disruptions between the human and gibbon genomes. Authors include Sanger's Jane Rogers, Baylor's Aleksandar Milosavljevic, and Pieter de Jong of the Children's Hospital of Oakland Research Institute. (Thu, 02 Jul 2009 05:18:23 GMT)
Special Data Needs Special Treatment
At his Genetic Future blog, Daniel MacArthur gives his two cents on a recent perspective article in Nature Reviews Genetics that discusses the ethical challenges of whole genome sequencing . MacArthur dissects the possible difficulties of getting the right data into the hands of consumers. (Thu, 02 Jul 2009 05:18:13 GMT)
Genes Are So Passé
What is a " gene ?" asks Bora Zivkovic. It used to be a unit of heredity, but is it now a stretch of DNA? Or something else? A new, philosophical article in PLoS One by Evelyn Fox Keller and David Harel delves into the definition of a gene and comes up with an alternative to the concept and word of "gene." (Thu, 02 Jul 2009 05:18:03 GMT)
That's One Long To-Do List
President-elect Obama was the first major political candidate to leverage the Internet for networking and communication, and it doesn’t look like he’s stopping that train. (Thu, 02 Jul 2009 05:17:53 GMT)
Scientists Find Differences in Embryonic Stem Cells and Reprogrammed Skin Cells
UCLA researchers have found that embryonic stem cells and skin cells reprogrammed into embryonic-like cells have inherent molecular differences, demonstrating for the first time that the two cell types are clearly distinguishable from one another. (Thu, 02 Jul 2009 04:31:25 GMT)
PM promises private school style education for all
Gordon Brown guarantees an education individually tailored for each child, but parents could be fined if they refuse to take more responsibility for their children's behaviour Parents should be able to expect a private school style education under plans to reform the education system, the prime minister said today. Families will be guaranteed personal tutors, one-to-one tuition, and a range of ... (Thu, 02 Jul 2009 02:17:38 GMT)
UB to host major biomedical ontology conference
Whether and how medical personnel and their digital systems can talk to one another in a meaningful way is a subject pertinent to the health of patients about whom they “converse.” (Wed, 01 Jul 2009 23:25:19 GMT)
DNASTAR, Inc. launches latest version of next generation sequencing software
DNASTAR, Inc. introduced today its latest version of Next-Gen sequence assembly software for desktop computers. NGen2.0 is the company’s third upgrade of NGS software in the past 18 months, reflecting the rapidly changing needs of the market. (Wed, 01 Jul 2009 23:03:34 GMT)
Common Gene Variations Linked to Schizophrenia, Scientists Say
July 1 (Bloomberg) -- Common variations in genes may underlie schizophrenia, the mental illness known to run in families for more than 100 years, with no one single variation conferring the majority of risk, three studies show. (Wed, 01 Jul 2009 22:02:25 GMT)
U of L helps find breakthrough on kidney ailment
A team including University of Louisville researchers has found the key to a debilitating disease in which the immune system attacks the kidneys — a discovery that could lead to earlier diagnosis and new medicines for a chronic condition afflicting 100,000 Americans. (Wed, 01 Jul 2009 21:44:06 GMT)
Microbial analysis, micropatterning methods featured in Cold Spring Harbor Protocols
( Cold Spring Harbor Laboratory ) The July issue of Cold Spring Harbor Protocols presents a method for quantifying populations of microorganisms in a variety of naturally occurring conditions such as plankton samples or biofilms, as well as a simple, fast and efficient method for generating micropatterns for cellular studies. Both methods are freely accessible on the Web site for Cold Spring ... (Wed, 01 Jul 2009 20:23:32 GMT)
Illumina Announces Preliminary Revenue for Second Quarter 2009
SAN DIEGO----Illumina, Inc. today announced, based on management's preliminary financial review, second quarter revenue of approximately $161 million compared to guidance of $168 to $173 million. (Wed, 01 Jul 2009 20:01:00 GMT)
GWC Lands $110K NSF Stimulus Grant to Develop Protein Biochip
NEW YORK (GenomeWeb News) – The proteomics products company GWC Technologies said today that it has received a Small Business Innovation Research grant from the National Science Foundation to continue developing its Carbon-on-Metal protein array analysis technology. (Wed, 01 Jul 2009 19:48:13 GMT)
BlueGnome to Distribute PicoPlex Technology from Rubicon Genomics
ANN ARBOR, Mich.----Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable optimal performance of advanced genetic analysis tools, announced today that it has reached agreement with BlueGnome to non-exclusively market its PicoPlex™ technology to In Vitro Fertilization researchers under the name SurePlex DNA Amplification System as part of the BlueGnome 24sure ... (Wed, 01 Jul 2009 19:31:00 GMT)
Barnes-Jewish Hospital launches $50M campaign for cancer research
The Barnes-Jewish Hospital Foundation has launched a 10-year, $50 million fundraising effort to accelerate breakthroughs in cancer prevention, diagnosis, treatment and cures. (Wed, 01 Jul 2009 18:44:36 GMT)
Canadian Initiative Developing Platform to Map Human Interactome, Eyes International Consortium
A multi-million dollar effort to create a technology platform to map the human interactome is underway in Canada with an eye to making it international. (Wed, 01 Jul 2009 17:47:53 GMT)
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
( Porter Novelli ) Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin (trastuzumab), is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists ... (Wed, 01 Jul 2009 17:14:28 GMT)
Fate Therapeutics Licenses Stem-Cell Modulators for Bone Regeneration from UCLA
Stem cell therapeutics company Fate Therapeutics said today that it has acquired from the University of California, Los Angeles, exclusive intellectual property rights covering small molecule compositions and methods for inducing bone formation. (Wed, 01 Jul 2009 16:32:53 GMT)
Sequencing the Teddy Bear
Sean Eddy's blog pointed us to Kevin Larry's "mildly enthused" interview with Cofactor Genomics, in which the co-founders detail "one of the more challenging projects they've worked on" — the teddy bear genome. (Wed, 01 Jul 2009 16:17:53 GMT)
Signature Genomic Laboratories Announces Appointment of New Laboratory Directors
SPOKANE, Wash.----Signature Genomic Laboratories has appointed two new laboratory directors, Drs. Marilyn Slovak, Ph.D., and J. Britt Ravnan, Ph.D. Signature, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, anticipates the appointments will help the company manage its steadily increasing volume of cases. (Wed, 01 Jul 2009 16:08:00 GMT)
Cancer Run-Down
The cancer labs of Elizabeth Blackburn, Chad Mirkin, and Elaine Mardis and Rick Wilson get shout-outs in three US News & World Report articles. Blackburn is looking to exploit cancer cells' use of telomerase to engineer a way to kill the cells; she is also intrigued by lifestyle influences, such as exercise and nutrition, on telomerase levels. (Wed, 01 Jul 2009 15:48:34 GMT)
Like a Love Triangle
Roche is leaving PhRMA for BIO . Genentech, which Roche recently acquired, was a member of BIO and during the reorganization of the companies, Roche assets in the US became Genentech. (Wed, 01 Jul 2009 15:48:24 GMT)
Pehaps There Are Better Ways to Spend the Money
It's not just financial firms that are being looked at askance over the pay of executives and board members -- biotech companies are also feeling the heat, reports the Wall Street Journal . An article in the June issue of Nature Biotechnology analyzed the salaries of 51 UK biotech companies , finding the average compensation for a chief executive to be £297,947 (US$493,616), and noting that ... (Wed, 01 Jul 2009 15:48:13 GMT)
Secrets Of Scorpion Venom Revealed By Genetic Analysis
Transcriptomic tests have uncovered the protein composition of venom from the Scorpiops jendeki scorpion. Researchers writing in the open access journal BMC Genomics have carried out the first ever venom analysis in this arachnid, and discovered nine novel poison molecules, never before seen in any scorpion species. (Wed, 01 Jul 2009 15:10:53 GMT)
Genetic And Chromosomal Abnormalities In Embryos Detected By New Test
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis. (Wed, 01 Jul 2009 15:09:32 GMT)
Hall, Rosbash and Young share $500,000 Gruber neuroscience prize
( Robin Leedy & Associates, Inc. ) The 2009 neuroscience prize of the Peter and Patricia Gruber Foundation is being awarded to Jeffrey Hall, professor of neurogenetics at the University of Maine; Michael Rosbash, professor and director of the National Center for Behavioral Genomics at Brandeis University; and Michael Young, professor and head of the Laboratory of Genetics at Rockefeller ... (Wed, 01 Jul 2009 14:13:28 GMT)
New e-science service could accelerate cancer research
( University of Manchester ) The University of Manchester and the European Molecular Biology Laboratory's European Bioinformatics Institute have launched a major new e-science resource for biologists -- which could accelerate research into treatments for H1N1 flu and cancer. (Wed, 01 Jul 2009 13:46:24 GMT)
Cranes Software's FY09 Consolidated Revenues up 33% to Rs. 5,289 Million and PAT Higher by 6% to Rs. 1,213.1 Million
BANGALORE, India----Cranes Software International Ltd. , a Company that provides Enterprise Statistical Analytics and Engineering Simulation Software Products and Solutions across the globe, today announced its audited financial results for the quarter and year ended March 31, 2009. (Wed, 01 Jul 2009 13:17:00 GMT)
Secrets Of Scorpion Venom Revealed
Transcriptomic tests have uncovered the protein composition of venom from the Scorpiops jendeki scorpion. (Wed, 01 Jul 2009 12:25:28 GMT)
Researchers Show New Antioxidant Could Help Treat Cardiovascular Disease
Researchers at the University of Glasgow believe they have found a potential new treatment for cardiovascular disease which reduces blood pressure. Scientists at the British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC) used a recently-developed antioxidant called MitoQ10 to prevent damage to the mitochondria of cells in an experimental model of hypertension and stroke. (Wed, 01 Jul 2009 12:25:28 GMT)
Hunt For Blood Test To Determine Melanoma Survival Rates
Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form. Melanoma is the most aggressive form of skin cancer. (Wed, 01 Jul 2009 10:22:52 GMT)
Genetic analysis reveals secrets of scorpion venom
Transcriptomic tests have uncovered the protein composition of venom from the Scorpiops jendeki scorpion. Researchers writing in the open access journal BMC Genomics have carried out the first ever venom analysis in this arachnid, and discovered nine novel poison molecules, never before seen in any scorpion species. (Wed, 01 Jul 2009 10:03:36 GMT)
Rubicon Genomics Introduces PicoPlex Single Cell Whole Genome Amplification Kit For Pre-Implantation Genetic ...
Rubicon Genomics, Inc., a developer of pre-amplification products that enable optimal performance of the most advanced genetic analysis tools, announced today the release of its PicoPlex Single Cell Whole Genome Amplification (WGA) kit-a more rapid, accurate and reproducible method for amplifying single genomes than current technologies. (Wed, 01 Jul 2009 09:31:10 GMT)
Exiqon Announces 2009 North American Grant Award Winners
Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the two winners of their 2009 North American Grant Program. Exiqon had recently announced the development of a new research grant program, open to researchers from academic and non-profit institutions across North America, engaged in microRNA research. (PRWeb Jul 1, 2009) Read the full story at ... (Wed, 01 Jul 2009 07:09:18 GMT)
Exiqon Announces 2009 North American Grant Award Winners
Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the two winners of their 2009 North American Grant Program. Exiqon had recently announced the development of a new research grant program, open to researchers from academic and non-profit institutions across North America, engaged in microRNA research. (Wed, 01 Jul 2009 07:01:00 GMT)
At ISMB, U Manchester Releases Biocatalogue, a Web Services Registry and Social Networking Hub
STOCKHOLM, Sweden – The University of Manchester today launched Biocatalogue , a registry of curated life science web services intended to help scientists easily connect with teams offering web-based bioinformatics resources. (Wed, 01 Jul 2009 06:47:53 GMT)
Or 280 Billion Haagen-Dazs Bars
If you had the choice between buying 32,407 Alvin submarines or bailing out the US economy, what would you do? (We know, it's a tough call.) Jonathan Eisen tries to get his head around the $700 billion bailout effort here in the US by blogging about what else that money could buy . His list includes: 280,000 liters of Taq polymerase, 538 million open access fees for publishing in PLoS One, and ... (Wed, 01 Jul 2009 05:18:33 GMT)
Chalk One Up for Scientific Destiny
As part of the Scientiae blog carnival , ScienceWoman writes about how her career goals changed from when she began her PhD -- "I'll either focus on teaching or on research, but I don't want a job where I have to be good at both" -- to now, as an assistant professor. (Wed, 01 Jul 2009 05:18:23 GMT)
MS vs PhD
Should you have stopped at your Master’s degree? Derek Lowe on his blog discusses whether it's worth getting a PhD. As he sums it up, it's easier to get hired as a non-PhD, but more difficult to advance very far. While PhDs can advance, they have a tougher time landing that hard-to-come-by job. (Wed, 01 Jul 2009 05:18:13 GMT)
Making the Decision Might Be the Toughest Part
At Brian Switek's Laelaps blog, he writes a heartfelt post, chronicling what he calls his "tortuous academic path to date." For some vicarious living, and maybe to feel better about the fact that you've actually made it into graduate school without that much existential angst, check out his post here . (Wed, 01 Jul 2009 05:18:03 GMT)
New Test Can Detect Both Genetic And Chromosomal Abnormalities In Embryos
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis. The technique, known as genomewide karyomapping, was capable of not only detecting diseases caused by a specific gene mutation, in this case ... (Wed, 01 Jul 2009 02:22:00 GMT)
Alpha Innotech Announces the Election of Two New Board Members
SAN LEANDRO, Calif.----Alpha Innotech Corp. , a leading provider of gel imaging systems for drug discovery and life science research, announced that Mssrs. Chris van Ingen and Dr. Shahram Hejazi were elected to its Board of Directors during the Company's most recent annual meeting. (Wed, 01 Jul 2009 01:14:00 GMT)
Genetic analysis reveals secrets of scorpion venom
Transcriptomic tests have uncovered the protein composition of venom from the Scorpiops jendeki scorpion. Researchers writing in the open access journal BMC Genomics have carried out the first ever venom analysis in this arachnid, and discovered nine novel poison molecules never before seen in any scorpion species. (Tue, 30 Jun 2009 23:13:18 GMT)
SEC Investigating Sequenom over Down Syndrome Test
NEW YORK (GenomeWeb News) – Sequenom disclosed in a filing with the US Securities and Exchange Commission today that the SEC is investigating the firm over its announcement in late April regarding the mishandling of R&D test data and results for its SEQureDx Down syndrome test. (Tue, 30 Jun 2009 22:17:53 GMT)
Who Will Helm Kaiser's Molecular Genetics Lab? Permanente Search Enters Fifth Week
Kaiser Permanente has been looking to hire a director for its molecular genetics laboratory in San Jose, Calif. The search, which is being conducted through at least four online job-recruitment web sites, has been going on for at least five weeks. (Tue, 30 Jun 2009 21:33:46 GMT)
Myriad Genetics' Q4, FY 2009 Revenues to Come Up Short
NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market Tuesday that it expects its fourth-quarter and full-year 2009 molecular diagnostic revenues to be lower than previously expected. (Tue, 30 Jun 2009 21:33:36 GMT)
Researchers using microRNA to identify aggressive melanoma
Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form. (Tue, 30 Jun 2009 20:42:16 GMT)
ViraCor, IBT to Merge
NEW YORK (GenomeWeb News) – ViraCor Laboratories and IBT Laboratories announced today that they will merge to form a new specialty diagnostic testing lab. (Tue, 30 Jun 2009 19:48:33 GMT)
Castle Biosciences to work with St. Joseph’s Hospital on brain cancer test
Castle Biosciences Inc. has joined with St. Joseph’s Hospital and Medical Center in Phoenix to provide the nation’s first genomics-based test for patients suffering from glioblastoma multiforme — the most deadly form of primary brain cancer. (Tue, 30 Jun 2009 18:59:25 GMT)
Aushon Technology Chosen for Small Molecule Microarray Research
BILLERICA, Mass.----Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis recently announced that the Eli and Edythe L. (Tue, 30 Jun 2009 18:30:00 GMT)
Horse Racing Enters Proteomics Age: UK Firm Developing Technology to Detect Steroid Use in Ponies
It isn't only baseball players and track stars who dope up to gain an upper hand on the playing field. Horse trainers and owners do also. (Tue, 30 Jun 2009 17:47:53 GMT)
Enabled by New Sequencing Techs, JGI Projects 300 GB of Data for 2010 Community Sequencing Program
New sequencing technologies will play an important role in 71 new genomic sequencing projects that the Department of Energy's Joint Genome Institute announced yesterday for its 2010 Community Sequencing Program. (Tue, 30 Jun 2009 17:33:04 GMT)
Gentel Biosciences Launches APiX Chromogenic Protein Array System
MADISON, Wis.----Gentel Biosciences, Inc., a leading protein microarray technologies firm, announced today the availability of its APiX™ Chromogenic Protein Array System to the global research community. (Tue, 30 Jun 2009 17:24:00 GMT)
Q&A: BC Cancer Agency's Robert Holt on Sequencing the Immune Repertoire
Rob Holt has been heading sequencing at the British Columbia Cancer Agency's Genome Sciences Centre since 2002, after spending four years at Celera Genomics. (Tue, 30 Jun 2009 17:18:21 GMT)
Invitrogen Positions New Array System for HLA-Testing Market
Invitrogen this week expanded its microarray portfolio with the debut of its Prodigy system, an automated instrument designed to help develop immunogenetic tests, such as human leukocyte antigen typing. (Tue, 30 Jun 2009 17:18:10 GMT)
Paired Ends
French immunologist Jean Dausset died earlier this month at the age of 92. In 1958, he discovered the human leukocyte antigen, HLA, and shared the Nobel Prize for medicine in 1980 with George Snell and Baruj Benacerraf . In 1984, Dausset founded the Centre d'Etude du Polymorphisme Humain , today called the Foundation Jean Dausset-CEPH , which helped create a genetic and physical map of the human ... (Tue, 30 Jun 2009 17:03:23 GMT)
New Products
Biomatters has released Geneious 4.7 beta , a new version of its bioinformatics sequence analysis platform. Version 4.7 includes a new DNA sequence assembler that allows users to align sequences generated on the Sanger and 454 platforms to a reference genome. (Tue, 30 Jun 2009 17:03:13 GMT)
Bayer Deal Not Enough for Celera
Bayer Deal Not Enough for Celera (Tue, 30 Jun 2009 16:54:40 GMT)
Test Can Detect Both Genetic And Chromosomal Abnormalities In Embryos
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis.They told a news briefing at the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam today ... (Tue, 30 Jun 2009 16:41:29 GMT)
This Week in PNAS
In PNAS this week, Steven Gygi at Harvard led work that used stable-isotope dilution and high-resolution mass spec to measure kinase activity. His multiplexed assay was able to measure up to 90 site-specific peptide phosphorylation rates at the same time, and he could apply it to a variety of cells and cellular processes, including mitogen stimulation, cell cycle, pharmacological inhibition of ... (Tue, 30 Jun 2009 16:32:56 GMT)
New Biomarker Method Could Increase The Number Of Diagnostic Tests For Cancer
A team of researchers has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. (Tue, 30 Jun 2009 16:10:03 GMT)
Q&A: Belgian Cyto Lab to Evaluate OGT's Arrays for Prenatal Diagnostics Service
Background: Vermeesch heads the constitutional cytogenetics unit of the Center of Human Genetics in Katholieke Universiteit Leuven. Previously he was head of the genomics unit in the basic research division of Aventis CropScience. He holds a PhD in biochemistry from the University of Nebraska. (Tue, 30 Jun 2009 16:02:53 GMT)
Rubicon Genomics Introduces PicoPlex Single Cell Whole Genome Amplification Kit for Pre-Implantation Genetic ...
ANN ARBOR, Mich.----Rubicon Genomics, Inc., a developer of pre-amplification products that enable optimal performance of the most advanced genetic analysis tools, announced today the release of its PicoPlex™ Single Cell Whole Genome Amplification kit--a more rapid, accurate and reproducible method for amplifying single genomes than current technologies. (Tue, 30 Jun 2009 15:32:00 GMT)
New Take On Growth Factor Signaling In Tamoxifen Resistance
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling. (Tue, 30 Jun 2009 14:37:35 GMT)
Over 25 New Features in Geneious(TM) 4.7
AUCKLAND, NEW ZEALAND--(Marketwire - June 30, 2009) - GeneiousT 4.7 boasts a new ultra-fast sequence assembler that allows users to assemble sequences generated from the Sanger and 454 high-throughput methods to a reference genome. GeneiousT version 4.7 is the first release in a three-phase release-strategy that will provide increasing support for next-generation high-throughput sequence data ... (Tue, 30 Jun 2009 13:34:01 GMT)
Hunt For The Blood Test To Determine Melanoma Survival Rates
New research will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form. Melanoma is the most aggressive form of skin cancer. Staging, which involves determining the size of the tumor and its extent of spread, is the best predictor of whether a patient will succumb to disease or survive. (Tue, 30 Jun 2009 13:21:03 GMT)
New test can detect both genetic and chromosomal abnormalities in embryos
( European Society for Human Reproduction and Embryology ) One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis (Tue, 30 Jun 2009 13:13:48 GMT)
Hunt for Blood Test to Determine Melanoma Survival Rates
(PhysOrg.com) -- Research at the University of Leicester will be breaking new ground in the search for a simple blood test that could tell whether a patient with melanoma has the condition in an aggressive form. (Tue, 30 Jun 2009 12:03:17 GMT)
Senator Kohl: Marshfield Clinic set the standard for quality health care
Sen. Herb Kohl said Monday that the Marshfield Clinics level of patient care, costs and constant push to move medicine forward, make it an example for a nation, and government, debating major health care reform. (Tue, 30 Jun 2009 12:02:52 GMT)
Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 ...
LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample can be entirely visualised in a single gel. (Tue, 30 Jun 2009 10:15:14 GMT)
New test detects genetic and chromosomal abnormalities in embryos - ready for clinical trials
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis. (Tue, 30 Jun 2009 10:12:21 GMT)
New pieces in the autism inheritance puzzle
Pieces in the complex autism inheritance puzzle are emerging in the latest study from a research team including geneticists from the University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia (CHOP). The study identified 27 different genetic regions where rare copy number variations - missing or extra copies of DNA segments - were found in the genes of children ... (Tue, 30 Jun 2009 09:42:26 GMT)
GPUs: Here to Stay
Sometimes it's the ubiquitous technologies that are the most overlooked. Such is the case with GPUs, which have largely gone unnoticed though they've lived inside our laptops and desktops for quite some time. (Tue, 30 Jun 2009 05:17:53 GMT)
Gene map aims to combat blood flukes
( BioMed Central ) The first microsatellite-based genetic linkage map has been published for Schistosoma mansoni, a blood fluke that is known to infect over 90 million people in Africa, the Middle East and the New World. Researchers writing in BioMed Central's open-access journal Genome Biology hope the map will stimulate research and open doors to new advances in combating this neglected human ... (Mon, 29 Jun 2009 23:23:31 GMT)
Broad Institute Develops GenomeSpace Platform to Integrate -Omics Tools, Enable Reproducible Workflows
STOCKHOLM, Sweden — The Broad Institute is following on its GenePattern analysis suite with a platform called GenomeSpace that will integrate six open source bioinformatics tools and eventually enable other developers to add their own software. (Mon, 29 Jun 2009 22:02:53 GMT)
IDBS said the acquisition will allow it to "expand its large scale data integration activities to support ...
IDBS said the acquisition will allow it to "expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine." (Mon, 29 Jun 2009 20:47:53 GMT)
Juvaris to Use Antigen Discovery's Protein Microarray Screening System
NEW YORK (GenomeWeb News) – Juvaris BioTherapeutics will use Antigen Discovery's high-throughput protein microarray screening system to discover disease-specific antigens for use in vaccines, Juvaris said today. (Mon, 29 Jun 2009 20:03:23 GMT)
Analyst Raises Valuations on Illumina, Life Technologies
NEW YORK (GenomeWeb News) – Investment bank Leerink Swann has raised its valuations on the stocks o Illumina and Life Technologies, citing the benefit of upcoming stimulus funding and expected gains in the next-generation sequencing market. (Mon, 29 Jun 2009 20:03:13 GMT)
defense molecules in mouth found to inhibit infections from HIV
A professor from the Case Western Reserve University School of Dental Medicine has discovered defense molecules found in the mouth inhibit infections from HIV. (Mon, 29 Jun 2009 19:48:24 GMT)
Microsoft Offers Updates from BioIT Alliance
At the recent the Bio-IT World Conference & Expo, Rudy Potenzone, Microsoft's industry technology strategist for pharmaceuticals, presented a panel of diverse collaborations underway through the BioIT Alliance, an organization Microsoft formed in 2006 to link vendors in the life sciences space to "explore new ways" of data sharing and to better leverage IT to foster personalized medicine. (Mon, 29 Jun 2009 19:47:53 GMT)
Novel epigenetic markers of melanoma may herald new treatments for patients
( Cold Spring Harbor Laboratory ) Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually. As incidences continue to rise, the race is on to find the genetic and cellular changes driving melanoma, and to devise new means of detection and treatment. In a study published online in Genome Research, scientists have found new ... (Mon, 29 Jun 2009 19:46:04 GMT)
New British Genomics Center To Focus On Improving Crop Plants
A new research center from Britain's Biotechnology Research Council (BBSRC) will decode the DNA of plants and animals used in agriculture in an effort to help farmers boost food production, BBC News reported.Economically and socially important plants such as wheat and ryegrass will be among the research conducted at the center.Experts also hope the research could present new ways of breeding ... (Mon, 29 Jun 2009 19:13:09 GMT)
Preimplantation Genetic Screening: Polar Body Screening Study Launched
The efficacy of preimplantation genetic screening (PGS) has been one of the most hotly disputed subjects in assisted reproduction over the past few years. None of the trials carried out so far has shown conclusively whether it works or not. Now scientists have decided to try to find out if a novel method of doing PGS using polar body biopsy and chromosome array analysis offers a possible solution. (Mon, 29 Jun 2009 18:20:44 GMT)
New biomarker method could increase the number of diagnostic tests for cancer
A team of researchers, including several from UCSF, has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. The researchers have developed a method to ... (Mon, 29 Jun 2009 17:18:36 GMT)
New biomarker method could increase the number of diagnostic tests for cancer
( University of California - San Francisco ) A team of researchers, including several from UCSF, has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. (Mon, 29 Jun 2009 17:14:29 GMT)
Juvaris, ADi in vaccine collaboration
Juvaris BioTherapeutics Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, on Monday announced a collaborative agreement with Antigen Discovery Inc. (Mon, 29 Jun 2009 17:05:56 GMT)
Pakistani science receives funding boost
[ISLAMABAD] Pakistan has increased its science and technology budget by a quarter, boosting funding to science projects across a range of ministries. Pakistan's National Assembly approved the budget last week (25 June). (Mon, 29 Jun 2009 16:56:55 GMT)
Going Generic
Philadelphia-based Mylan and India-based Biocon are teaming up to develop generic biotech drugs . "It makes sense that Mylan, which is an expert in making generic copies of traditional drugs, would partner with an outside firm that focuses on biotech. (Mon, 29 Jun 2009 16:33:03 GMT)
Try Again with that Proposal
Bitesize Bio's Douglas McCormick points out that the US National Institutes of Health issued RFAs for research into a variety of area s -- the National Cancer Institute has $50 million to $55 million to fund biomarker research, and $25 million to $30 million for cancer intervention and surveillance modeling. (Mon, 29 Jun 2009 16:32:53 GMT)
Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery, Inc.
BURLINGAME, Calif.----Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced the signing of a definitive agreement with Antigen Discovery, Inc. to access ADi's proprietary high-throughput protein microarray screening system to discover novel disease-specific antigens to fuel Juvaris' vaccine pipeline. (Mon, 29 Jun 2009 16:30:00 GMT)
febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
Generation Sequencing Within Days (Mon, 29 Jun 2009 14:36:00 GMT)
Celera Grants Bayer Cancer Rx License; Retains Companions Dx Rights
NEW YORK (GenomeWeb News) – Celera today said that it has licensed exclusive worldwide rights to Bayer Schering Pharma for five cancer-related drug targets and associated in vivo diagnostic imaging. (Mon, 29 Jun 2009 14:32:53 GMT)
Chugai Licenses Genedata’s Software
NEW YORK (GenomeWeb News) – Tokyo-based Chugai Pharmaceutical has signed a multi-year license agreement with Genedata for the use of its biomarker discovery software in R&D programs, the Swiss bioinformatics company said today. (Mon, 29 Jun 2009 14:18:47 GMT)
BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
INDIANAPOLIS, June 29 /PRNewswire/ -- BioStorage Technologies, Inc. (Mon, 29 Jun 2009 14:02:06 GMT)
Crop plants get genomics centre
A UK research centre to decode the DNA of plants and animals used in agriculture will open this week in the east of England. (Mon, 29 Jun 2009 12:58:58 GMT)
New Biomarker Method Could Increase the Number of Diagnostic Tests for Cancer
A team of researchers has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. (Mon, 29 Jun 2009 12:42:51 GMT)
Invitrogen Launches New Microarray System to Simplify Immunogenetic Testing
CARLSBAD, Calif.----Invitrogen, part of Life Technologies Corporation , today announced the commercial availability of a state-of-the-art, automated, research-use microarray system designed to simplify immunogenetic testing, including human leukocyte antigen research. (Mon, 29 Jun 2009 11:30:00 GMT)
International Study Of Polar Body Screening Launced By ESHRE
The efficacy of preimplantation genetic screening (PGS) has been one of the most hotly disputed subjects in assisted reproduction over the past few years. None of the trials carried out so far has shown conclusively whether it works or not. (Mon, 29 Jun 2009 11:09:13 GMT)
